Korea Investment Corp Teva Pharmaceutical Industries LTD Transaction History

Korea Investment Corp

  • $41.3 Billion
  • Q3 2024

A detailed history of Korea Investment Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Korea Investment Corp holds 222,056 shares of TEVA stock, worth $5.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
222,056
Previous 220,756 0.59%
Holding current value
$5.02 Million
Previous $3.59 Million 11.54%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$15.81 - $18.96 $20,553 - $24,648
1,300 Added 0.59%
222,056 $4 Million
Q2 2024

Aug 13, 2024
SELL
$12.78 - $17.4 $47,286 - $64,379
-3,700 Reduced 1.65%
220,756 $3.59 Million
Q1 2024

May 14, 2024
BUY
$10.67 - $14.43 $11,704 - $15,829
1,097 Added 0.49%
224,456 $3.17 Million
Q4 2023

Feb 13, 2024
BUY
$8.12 - $10.63 $210,925 - $276,124
25,976 Added 13.16%
223,359 $2.33 Million
Q3 2023

Nov 13, 2023
SELL
$7.48 - $10.7 $246,914 - $353,207
-33,010 Reduced 14.33%
197,383 $2.01 Million
Q2 2023

Aug 11, 2023
BUY
$7.2 - $9.47 $139,680 - $183,718
19,400 Added 9.19%
230,393 $1.73 Million
Q1 2023

May 12, 2023
SELL
$8.36 - $11.37 $429,578 - $584,247
-51,385 Reduced 19.58%
210,993 $1.87 Million
Q4 2022

Feb 13, 2023
SELL
$7.95 - $9.48 $37,237 - $44,404
-4,684 Reduced 1.75%
262,378 $2.39 Million
Q3 2022

Nov 10, 2022
BUY
$6.86 - $11.95 $541,679 - $943,595
78,962 Added 41.98%
267,062 $2.16 Million
Q2 2022

Aug 12, 2022
BUY
$7.38 - $10.4 $50,184 - $70,720
6,800 Added 3.75%
188,100 $1.42 Million
Q1 2022

May 13, 2022
BUY
$7.33 - $9.39 $353,306 - $452,598
48,200 Added 36.21%
181,300 $1.7 Million
Q4 2021

Feb 09, 2022
BUY
$7.9 - $10.19 $101,910 - $131,451
12,900 Added 10.73%
133,100 $1.07 Million
Q3 2021

Nov 12, 2021
SELL
$8.38 - $10.18 $44,414 - $53,954
-5,300 Reduced 4.22%
120,200 $1.17 Million
Q2 2021

Aug 12, 2021
BUY
$9.9 - $11.56 $195,030 - $227,732
19,700 Added 18.62%
125,500 $1.24 Million
Q1 2021

May 13, 2021
SELL
$10.34 - $12.81 $3.55 Million - $4.39 Million
-342,855 Reduced 76.42%
105,800 $1.22 Million
Q4 2020

Feb 10, 2021
SELL
$8.61 - $11.04 $440,832 - $565,248
-51,200 Reduced 10.24%
448,655 $4.33 Million
Q3 2020

Nov 12, 2020
SELL
$8.57 - $12.69 $7,713 - $11,421
-900 Reduced 0.18%
499,855 $4.5 Million
Q2 2020

Aug 12, 2020
SELL
$8.12 - $13.12 $1.1 Million - $1.77 Million
-135,200 Reduced 21.26%
500,755 $6.17 Million
Q1 2020

May 14, 2020
BUY
$6.69 - $13.45 $832,905 - $1.67 Million
124,500 Added 24.34%
635,955 $5.71 Million
Q4 2019

Feb 11, 2020
BUY
$6.53 - $10.72 $191,982 - $315,168
29,400 Added 6.1%
511,455 $5.01 Million
Q3 2019

Nov 12, 2019
BUY
$6.16 - $9.6 $55,440 - $86,400
9,000 Added 1.9%
482,055 $3.32 Million
Q2 2019

Aug 12, 2019
SELL
$8.12 - $15.72 $1.04 Million - $2.01 Million
-127,600 Reduced 21.24%
473,055 $4.37 Million
Q1 2019

May 15, 2019
BUY
$15.58 - $20.01 $373,920 - $480,240
24,000 Added 4.16%
600,655 $9.42 Million
Q4 2018

Feb 13, 2019
SELL
$14.59 - $23.84 $422,789 - $690,835
-28,978 Reduced 4.78%
576,655 $8.89 Million
Q3 2018

Nov 13, 2018
BUY
$21.06 - $25.65 $1.11 Million - $1.35 Million
52,600 Added 9.51%
605,633 $13 Million
Q2 2018

Aug 13, 2018
BUY
$16.77 - $24.71 $2.01 Million - $2.96 Million
119,900 Added 27.68%
553,033 $0
Q1 2018

May 09, 2018
BUY
$16.68 - $22.07 $3.06 Million - $4.05 Million
183,300 Added 73.37%
433,133 $7.4 Million
Q4 2017

Feb 12, 2018
BUY
$11.23 - $19.1 $56,812 - $96,626
5,059 Added 2.07%
249,833 $4.73 Million
Q3 2017

Oct 25, 2017
BUY
$15.41 - $32.17 $3.77 Million - $7.87 Million
244,774
244,774 $4.31 Million

Others Institutions Holding TEVA

# of Institutions
625
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Korea Investment Corp Portfolio

Follow Korea Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email